Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/08/2023 | Satsuma Pharmaceuticals, Inc. | STSA | Disposition | Stock Option (right to buy) | 20k | $4.60 | $92k | | 06/06/2023 |
06/08/2023 | Satsuma Pharmaceuticals, Inc. | STSA | Disposition | Stock Option (right to buy) | 30k | $3.46 | $103.8k | | 06/06/2023 |
06/08/2023 | Satsuma Pharmaceuticals, Inc. | STSA | Disposition | Stock Option (right to buy) | 10k | $26.99 | $269.9k | | 06/06/2023 |
06/06/2023 | Satsuma Pharmaceuticals, Inc. | STSA | Other | Common Stock, $0.0001 par value | 5.9M | $0.91 | $5.4M | See Footnote | 06/06/2023 |
05/16/2023 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Stock Option (Right to Buy) | 16.5k | $1.82 | $30k | See Footnote | 05/16/2023 |
06/10/2022 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Stock Option (Right to Buy) | 15k | $2.14 | $32.1k | See footnote | 06/10/2022 |
06/18/2021 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Stock Option (Right to Buy) | 15k | $12.55 | $188.2k | | 06/18/2021 |
06/17/2021 | Kala Pharmaceuticals, Inc. | KALA | Grant | | 20k | $0.00 | $0 | | 06/17/2021 |
06/16/2021 | Solid Biosciences Inc. | SLDB | Grant | Director Stock Option (Right to Buy) | 30k | $3.94 | $118.2k | | 06/16/2021 |
05/20/2021 | Black Diamond Therapeutics, Inc. | BDTX | Other (disposition) | Common Stock | 443 | $24.01 | $10.6k | | 05/20/2021 |
04/01/2021 | Black Diamond Therapeutics, Inc. | BDTX | Other (acquisition) | Common Stock | 353.8k | $24.26 | $8.6M | See Footnote | 04/01/2021 |
03/18/2021 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 443 | $24.01 | $10.6k | | 03/18/2021 |
12/10/2020 | Solid Biosciences Inc. | SLDB | Grant | Common Stock | 4.9M | $3.70 | $18.3M | See footnote | 12/10/2020 |
12/03/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Grant | Stock Option (Right to Buy) | 20k | $4.60 | $92k | | 12/03/2020 |
06/16/2020 | Solid Biosciences Inc. | SLDB | Grant | Director Stock Option (Right to But) | 30k | $3.03 | $90.9k | | 06/16/2020 |
06/12/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Grant | Stock Option (Right to Buy) | 10k | $26.99 | $269.9k | | 06/12/2020 |
05/27/2020 | Eidos Therapeutics, Inc. | EIDX | Grant | Stock Option (right to buy) | 21.5k | $48.51 | $1M | | 05/27/2020 |
04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Common Stock | 4.9M | $48.00 | $233.2M | See Footnote | 04/02/2020 |
04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Stock Option (Right to Buy) | 15k | $22.37 | $335.6k | | 04/02/2020 |
04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Stock Option (Right to Buy) | 15k | $9.90 | $148.5k | | 04/02/2020 |
04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Stock Option (Right to Buy) | 15k | $19.88 | $298.2k | | 04/02/2020 |
03/13/2020 | Kala Pharmaceuticals, Inc. | KALA | Purchase | Common Stock | 6.3M | $7.89 | $50M | See footnotes | 03/13/2020 |
02/03/2020 | Black Diamond Therapeutics, Inc. | BDTX | Conversion | Common Stock | 956.7k | $0.00 | $0 | See footnote | 02/03/2020 |
02/03/2020 | Black Diamond Therapeutics, Inc. | BDTX | Conversion | Common Stock | 163.4k | $0.00 | $0 | See footnote | 02/03/2020 |
02/03/2020 | Black Diamond Therapeutics, Inc. | BDTX | Conversion | Common Stock | 186.7k | $0.00 | $0 | See footnote | 02/03/2020 |
02/03/2020 | Black Diamond Therapeutics, Inc. | BDTX | Conversion | Common Stock | 30.5k | $0.00 | $0 | See footnote | 02/03/2020 |
02/03/2020 | Black Diamond Therapeutics, Inc. | BDTX | Purchase | Common Stock | 785.7k | $19.00 | $14.9M | See footnote | 02/03/2020 |
02/03/2020 | Black Diamond Therapeutics, Inc. | BDTX | Purchase | Common Stock | 77.8k | $19.00 | $1.5M | See footnote | 02/03/2020 |
02/03/2020 | Black Diamond Therapeutics, Inc. | BDTX | Purchase | Common Stock | 136.5k | $19.00 | $2.6M | See footnote | 02/03/2020 |
02/03/2020 | Black Diamond Therapeutics, Inc. | BDTX | Conversion | Series B Preferred Stock | 2.9M | $0.00 | $0 | See footnote | 02/03/2020 |
02/03/2020 | Black Diamond Therapeutics, Inc. | BDTX | Conversion | Series B Preferred Stock | 492.6k | $0.00 | $0 | See footnote | 02/03/2020 |
02/03/2020 | Black Diamond Therapeutics, Inc. | BDTX | Conversion | Series B Preferred Stock | 563.2k | $0.00 | $0 | See footnote | 02/03/2020 |
02/03/2020 | Black Diamond Therapeutics, Inc. | BDTX | Conversion | Series C Preferred Stock | 548.2k | $0.00 | $0 | See footnote | 02/03/2020 |
02/03/2020 | Black Diamond Therapeutics, Inc. | BDTX | Conversion | Series C Preferred Stock | 213.4k | $0.00 | $0 | See footnote | 02/03/2020 |
02/03/2020 | Black Diamond Therapeutics, Inc. | BDTX | Conversion | Series C Preferred Stock | 92.1k | $0.00 | $0 | See footnote | 02/03/2020 |
|